Cambridge, UK, 7th March 2022 – Microbiotica, a leading player in discovering and developing microbiome-based therapeutics and biomarkers, today announced the completion of a £50 million ($67 million) Series B financing round – the largest microbiome-related financing in Europe to date.
News
Cambridge, United Kingdom, 3rd March 2022 / Sciad Newswire / Domainex Ltd., a leading integrated medicines research services partner, announces that it has purchased over £1M worth of new Waters equipment to enhance its capabilities in analytical chemistry, bioanalytical sciences and in vitro absorbance, distribution, metabolism and excretion (ADME) assays. The new equipment will allow Domainex to increase its capacity and throughput, supporting its ongoing growth.
Stevenage Bioscience Catalyst (SBC) has launched an accelerator programme to give start-ups working on data-enabled drug discovery, genomics and advanced therapies the skills they need to get potential new drugs and therapies to market more quickly.
Cambridge, UK, 01 March 2022: PhoreMost Ltd., the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets, today announced the promotion of Dr Neil Torbett to Chief Executive Officer, with immediate effect. Dr Torbett was previously the Company’s Chief Operating Officer. Founder and former CEO, Dr Chris Torrance will become Chair of the Board.
AMSBIO reports how researchers at the Washington University School of Medicine (St. Louis, USA) have used their 10E4 Heparan Sulfate (HS) antibody in pioneering obesity research to quantify the role of HS in the process of intercellular mitochondria transfer to macrophages.
Cambridge, UK, 28th February 2022: Chesterford Research Park is delighted to welcome Broken String Biosciences to the Park’s eminent Science Village.
• Funding will support recruitment, commercial partnerships, and further development of Semarion’s SemaCyte cell assaying platform, which turns adherent cells into liquid reagents to enable novel drug screening methodologies
• Investors include Parkwalk Advisors, University of Cambridge Seed Funds, Martlet Capital, and angel investors
We are excited to announce the launch of our new course, providing the training and examination required to become a IRCA Accredited GMP Pharmaceutical Quality System Lead Auditor.
Following on from the successful PR330 IRCA QMS Pharmaceutical Suppliers ISO9001/PQG Lead Auditor course, RSSL is launching the new GMP Pharmaceutical Quality Systems (GMP/ICHQ10) Lead Auditor Course from Spring 2022!